Further using TGF-β1 (a TGF-β agonist) and sh Smad2/3, we determined the role of the TGF-β/Smad signaling axis in LIF-mediated GC cell proliferation, invasion, and migration. This evidence concerns the gene SMAD2 and gastric cancer.